The document is an intimation of an Investor Conference Call, a post-results investor interaction to discuss Q1 FY27 business performance and results.
The event is scheduled for Thursday, July 30, 2026, from 06:30 PM IST to 07:30 PM IST.
The stated purpose of the event is to discuss the company's Q1 FY27 business performance and results.
The meeting is scheduled after the earnings announcement for the quarter.
Management participants and their designations are provided:
Mr. Rajeev Juneja, Vice Chairman & Managing Director
Mr. Sheetal Arora, Chief Executive Officer & Whole Time Director
Mr. Arjun Juneja, Chief Operating Officer
Mr. Sudipta Roy, Senior President Sales & Marketing
Mr. Ashutosh Dhawan, Global Chief Financial Officer
Mr. Prakash Agarwal, President (Strategy)
The call will be conducted via Zoom, and registration is required through the provided link: https://us06web.zoom.us/webinar/register/WN_gjCF6TrYR9eK24zPRYSZQ.
The intimation is made pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which is standard compliance language for such disclosures.
Additional Notes Section
The document includes an enclosure (marked 'A/a'), which is the detailed invite for the earnings call.
No financial data, performance figures, guidance, or strategic updates were disclosed in this announcement. It is purely a notice of the upcoming event.
Contact details for investor relations (Mankind Pharma Limited) and public relations (Adfactors PR) are provided for operational purposes.
